propranolol has been researched along with Long QT Syndrome 1 in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gemma, LW | 1 |
| Ward, GM | 1 |
| Dettmer, MM | 1 |
| Ball, JL | 1 |
| Leo, PJ | 1 |
| Doria, DN | 1 |
| Kaufman, ES | 1 |
1 trial available for propranolol and Long QT Syndrome 1
| Article | Year |
|---|---|
β-blockers protect against dispersion of repolarization during exercise in congenital long-QT syndrome type 1.
Topics: Adrenergic beta-Antagonists; Adult; Death, Sudden, Cardiac; Double-Blind Method; Electrocardiography | 2011 |